We’re pleased to announce a new program aimed at reducing drug waste, in collaboration with OncoHealth, which conducts medical review of chemotherapeutic protocols for Harvard Pilgrim Health Care Commercial members. The new optional vial rounding program helps reduce drug waste and manage costs, including the patient’s out-of-pocket costs, by decreasing the member’s dosage within clinically appropriate ranges to prevent a subsequent vial from being opened, when most of that vial will go unused.
When you request prior authorization for a chemotherapy protocol through OncoHealth’s digital platform, the tool calculates the patient’s dose based on their specifics, such as height, weight and body surface area. If applicable, it will then provide a vial rounding recommendation, in which the dose is adjusted by no more than 10 percent. The provider has the option to accept or reject the change, as the example below shows.
If a provider opts to call OncoHealth for prior authorization, rather than use the portal, they will be asked select questions to allow for a vial rounding recommendation to be made.
This flyer offers more information on the vial rounding program. You can learn more about the OncoHealth utilization management review program by visiting the Vendor Programs page on the Point32Health website and the OncoHealth page dedicated for Harvard Pilgrim.
If you have any questions about vial rounding or need help accessing the OncoHealth OneUM provider portal, feel contact OncoHealth Client Support via email or at 888-916-2616.